D.W. Miles

2.3k total citations
55 papers, 1.8k citations indexed

About

D.W. Miles is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D.W. Miles has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 13 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D.W. Miles's work include Cancer Treatment and Pharmacology (23 papers), HER2/EGFR in Cancer Research (12 papers) and Immunotherapy and Immune Responses (8 papers). D.W. Miles is often cited by papers focused on Cancer Treatment and Pharmacology (23 papers), HER2/EGFR in Cancer Research (12 papers) and Immunotherapy and Immune Responses (8 papers). D.W. Miles collaborates with scholars based in United Kingdom, France and Spain. D.W. Miles's co-authors include L. G. Bobrow, B Davies, Frances R. Balkwill, RD Rubens, R.D. Rubens, Javier Cortés, Joyce Taylor‐Papadimitriou, Véronique Dièras, Xavier Pivot and Joyce O’Shaughnessy and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

D.W. Miles

54 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D.W. Miles 1.0k 616 579 320 295 55 1.8k
S. A. Eccles 1.1k 1.0× 807 1.3× 588 1.0× 215 0.7× 305 1.0× 45 2.1k
Franco Di Filippo 847 0.8× 477 0.8× 266 0.5× 254 0.8× 306 1.0× 80 1.9k
P Bertheau 800 0.8× 536 0.9× 456 0.8× 173 0.5× 234 0.8× 35 1.5k
Yasushi Kasai 721 0.7× 1.1k 1.8× 368 0.6× 253 0.8× 427 1.4× 64 2.1k
K. Pittman 903 0.9× 774 1.3× 502 0.9× 267 0.8× 686 2.3× 25 1.7k
Willem E. Corver 781 0.8× 833 1.4× 564 1.0× 617 1.9× 198 0.7× 81 2.2k
Ossi R. Köchli 861 0.8× 773 1.3× 552 1.0× 81 0.3× 247 0.8× 44 1.8k
Juan J. Roman 728 0.7× 568 0.9× 191 0.3× 599 1.9× 154 0.5× 27 1.8k
Emanuela Bonoldi 738 0.7× 801 1.3× 499 0.9× 163 0.5× 292 1.0× 80 1.9k
S A Cannistra 644 0.6× 816 1.3× 402 0.7× 502 1.6× 149 0.5× 11 2.4k

Countries citing papers authored by D.W. Miles

Since Specialization
Citations

This map shows the geographic impact of D.W. Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.W. Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.W. Miles more than expected).

Fields of papers citing papers by D.W. Miles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.W. Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.W. Miles. The network helps show where D.W. Miles may publish in the future.

Co-authorship network of co-authors of D.W. Miles

This figure shows the co-authorship network connecting the top 25 collaborators of D.W. Miles. A scholar is included among the top collaborators of D.W. Miles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.W. Miles. D.W. Miles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Earl, Helena, Louise Hiller, Julie Dunn, et al.. (2021). LBA11 Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer. Annals of Oncology. 32. S1283–S1283. 14 indexed citations
2.
3.
4.
5.
Lambrechts, Diether, D.W. Miles, Leonard B. Saltz, et al.. (2011). Genetic Markers in Relation to Bevacizumab-induced Hypertension. European Journal of Cancer. 47. 1 indexed citations
6.
Buzdar, Aman U., Binghe Xu, Raghunadharao Digumarti, et al.. (2011). Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer. Annals of Oncology. 23(3). 589–597. 11 indexed citations
7.
Miles, D.W., et al.. (2002). 13. NEW BIOLOGICAL THERAPIES FOR BREAST CANCER. International Journal of Clinical Practice. 56(4). 261–266. 9 indexed citations
8.
Miles, D.W., Ian E. Smith, Robert E. Coleman, A H Calvert, & Michael Lind. (2001). A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer. European Journal of Cancer. 37(11). 1366–1371. 57 indexed citations
9.
Coleman, Robert E., et al.. (2000). A Phase II study of docetaxel in patients with liver metastases from breast cancer. Annals of Oncology. 11(5). 541–546. 12 indexed citations
10.
Dowsett, Mitch, C. Pfister, D.W. Miles, et al.. (1999). Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.. PubMed. 5(9). 2338–43. 70 indexed citations
11.
Miles, D.W. & Joyce Taylor‐Papadimitriou. (1999). Therapeutic Aspects of Polymorphic Epithelial Mucin in Adenocarcinoma. Pharmacology & Therapeutics. 82(1). 97–106. 31 indexed citations
12.
13.
MacLean, Grant D., D.W. Miles, R.D. Rubens, Mark A. Reddish, & B. Michael Longenecker. (1996). Enhancing the Effect of THERATOPE STn-KLH Cancer Vaccine in Patients with Metastatic Breast Cancer by Pretreatment with Low-Dose Intravenous Cyclophosphamide. Journal of Immunotherapy. 19(4). 309–309. 126 indexed citations
14.
Miles, D.W., Lisa Happerfield, Lynda G. Bobrow, & R.D. Rubens. (1996). Adhesion molecule expression and leucocyte trafficking following immunotherapy with recombinant interleukin‐2. Histopathology. 28(4). 301–308. 3 indexed citations
15.
Miles, D.W. & R.D. Rubens. (1995). Transverse Leukonychia. New England Journal of Medicine. 333(2). 100–100. 5 indexed citations
16.
Miles, D.W., Lisa Happerfield, Paul Smith, et al.. (1994). Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. British Journal of Cancer. 70(6). 1272–1275. 67 indexed citations
17.
Davies, B, et al.. (1993). Activity of type IV collagenases in benign and malignant breast disease. British Journal of Cancer. 67(5). 1126–1131. 296 indexed citations
18.
Miles, D.W., et al.. (1991). High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study. Cancer Chemotherapy and Pharmacology. 27(5). 394–396. 27 indexed citations
19.
Taverner, D., et al.. (1966). Prevention of Denervation in Bell's Palsy. BMJ. 1(5484). 391–393. 38 indexed citations
20.
Peiris, O. A. & D.W. Miles. (1965). Galvanic stimulation of the tongue as a prognostic index in Bell's palsy.. BMJ. 2(5471). 1162–1163. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. A. Eccles Breakdown of academic impact, for papers by Franco Di Filippo Breakdown of academic impact, for papers by P Bertheau Breakdown of academic impact, for papers by Yasushi Kasai Breakdown of academic impact, for papers by K. Pittman Breakdown of academic impact, for papers by Willem E. Corver Breakdown of academic impact, for papers by Ossi R. Köchli Breakdown of academic impact, for papers by Juan J. Roman Breakdown of academic impact, for papers by Emanuela Bonoldi Breakdown of academic impact, for papers by S A Cannistra
Rankless by CCL
2026